Malignant Hepatobiliary Neoplasm — Trials

Malignant Hepatobiliary Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,025 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,159
Recruiting: 665
Ph III recruiting: 61
Growth YoY: +9%
Industry share: 22%
Top sponsor: Sun Yat-sen University
Termination share: 32.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (560)

clinicaltrialsPublishedShowing 101–150 of 394 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03475953	A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors(REGOMUNE)	unknown	Phase 1 / Phase 2	747	Institut BergoniéOTHER	1	Mar 3, 2023	clinicaltrials
NCT04992143	TACE+Tilelizumab+Sorafenib in the Treatment of BCLC Stage C HCC	unknown	Phase 2	20	First Affiliated Hospital of Zhejiang UniversityOTHER	1	Feb 16, 2023	clinicaltrials